- Home
- CAKE vs NVAX Comparison
CAKE vs NVAX Comparison
Compare CAKE & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- NVAX
- Stock Information
- Founded
- CAKE 1972
- NVAX 1987
- Country
- CAKE United States
- NVAX United States
- Employees
- CAKE N/A
- NVAX N/A
- Industry
- CAKE Restaurants
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAKE Consumer Discretionary
- NVAX Health Care
- Exchange
- CAKE Nasdaq
- NVAX Nasdaq
- Market Cap
- CAKE 2.0B
- NVAX 2.0B
- IPO Year
- CAKE 1992
- NVAX 1995
- Fundamental
- Price
- CAKE $47.79
- NVAX $9.76
- Analyst Decision
- CAKE Hold
- NVAX Buy
- Analyst Count
- CAKE 14
- NVAX 6
- Target Price
- CAKE $41.38
- NVAX $17.83
- AVG Volume (30 Days)
- CAKE 1.1M
- NVAX 7.2M
- Earning Date
- CAKE 10-29-2024
- NVAX 11-07-2024
- Dividend Yield
- CAKE 2.52%
- NVAX N/A
- EPS Growth
- CAKE 82.87
- NVAX N/A
- EPS
- CAKE 2.39
- NVAX N/A
- Revenue
- CAKE $3,502,484,000.00
- NVAX $987,667,000.00
- Revenue This Year
- CAKE $6.24
- NVAX N/A
- Revenue Next Year
- CAKE $5.72
- NVAX N/A
- P/E Ratio
- CAKE $17.90
- NVAX N/A
- Revenue Growth
- CAKE 2.74
- NVAX N/A
- 52 Week Low
- CAKE $29.27
- NVAX $3.53
- 52 Week High
- CAKE $43.73
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- CAKE 77.12
- NVAX 36.20
- Support Level
- CAKE $40.72
- NVAX $9.52
- Resistance Level
- CAKE $43.51
- NVAX $10.63
- Average True Range (ATR)
- CAKE 1.28
- NVAX 0.57
- MACD
- CAKE 0.52
- NVAX -0.12
- Stochastic Oscillator
- CAKE 99.28
- NVAX 9.97
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.